About
Mobia Medical, Inc.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions.
The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions.
Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.
Mobia Medical, Inc. Overview
Ticker, listing venue and issuer profile
Offer & Key Dates
Pricing terms and IPO milestones
Change from offer price to today
Live Market Snapshot
Real-time price; headline % change is vs first trade (listing price)
USD · NASDAQ:NASDAQ:MOBI
Valuation & Multiples
Key valuation ratios and metrics
Financial Health
Balance sheet strength and liquidity
Profitability & Returns
Margins and return on capital
Risk Metrics
Volatility versus the market
Financial Highlights
Historical financial performance
Historical Data
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | $13.20 | $13.30 | $12.61 | $13.10 | $13.10 | -0.10 | 66,600 |
| 2026-05-28 | $12.95 | $13.34 | $12.75 | $13.00 | $13.00 | +0.05 | 64,400 |
| 2026-05-27 | $13.09 | $13.19 | $12.60 | $12.98 | $12.98 | -0.11 | 64,500 |
| 2026-05-26 | $12.68 | $13.16 | $12.25 | $13.16 | $13.16 | +0.48 | 132,300 |
| 2026-05-22 | $12.60 | $12.75 | $12.40 | $12.60 | $12.60 | 0.00 | 78,500 |
| 2026-05-21 | $12.75 | $12.87 | $12.25 | $12.57 | $12.57 | -0.18 | 63,700 |
| 2026-05-20 | $12.07 | $12.76 | $12.07 | $12.75 | $12.75 | +0.68 | 71,200 |
| 2026-05-19 | $12.12 | $12.65 | $11.80 | $12.46 | $12.46 | +0.34 | 58,400 |
| 2026-05-18 | $12.02 | $12.50 | $11.66 | $12.37 | $12.37 | +0.35 | 56,700 |
| 2026-05-15 | $11.95 | $12.34 | $11.54 | $11.90 | $11.90 | -0.05 | 102,200 |
| 2026-05-14 | $12.14 | $12.15 | $11.59 | $12.05 | $12.05 | -0.09 | 67,700 |
| 2026-05-13 | $12.22 | $12.48 | $11.50 | $12.11 | $12.11 | -0.11 | 119,600 |
| 2026-05-12 | $12.03 | $12.16 | $11.67 | $12.10 | $12.10 | +0.07 | 162,900 |
| 2026-05-11 | $11.65 | $12.10 | $11.11 | $12.00 | $12.00 | +0.35 | 370,800 |
| 2026-05-08 | $14.00 | $14.00 | $10.19 | $11.75 | $11.75 | -2.25 | 2,507,900 |
| 2026-05-07 | $15.00 | $15.00 | $15.00 | $15.00 | $15.00 | 0.00 | 0 |
| 2026-05-06 | $15.00 | $15.00 | $15.00 | $15.00 | $15.00 | 0.00 | 0 |
SEC Filings
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| SCHEDULE 13G | May 18, 2026 | Filing |
| SCHEDULE 13D | May 15, 2026 | Filing |
| SCHEDULE 13G | May 15, 2026 | Filing |
| SCHEDULE 13D | May 13, 2026 | Filing |
| 8-K | May 11, 2026 | Current Report |
| S-8 | May 8, 2026 | Securities to be offered to employees in employee benefit plans |
| 424B4 | May 8, 2026 | Prospectus |
| EFFECT | May 7, 2026 | Notice of Effectiveness |
| CERT | May 7, 2026 | Certification by an exchange approving securities for listing |
| 8-A12B | May 7, 2026 | Registration of securities |
Company Info
Contact and headquarters details
Leadership
Key executives and officers
Richard Foust
President, Chief Executive Officer and Director
Nelson Bunker Curnes
Chief Financial Officer and Director
Douglas (Doug) Ellison
Chief Commercial Officer
Prashant Rawat
Chief Operating Officer
Thomas Jordan Curnes II
Co-Founder and Director
Chase Leavitt
General Counsel and Corporate Secretary
Dana G. Mead, Jr.
Chair of the Board
Casey Tansey
Director
William (Bill) Harrington
Director
Cynthia Lucchese
Director
